ARIYOSHI Yutaka | Department of Hematology and Chemotherapy, Aichi Cancer Center
スポンサーリンク
概要
関連著者
-
ARIYOSHI Yutaka
Department of Hematology and Chemotherapy, Aichi Cancer Center
-
NAOE Tomoki
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
KAGAMI Yoshitoyo
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
KANAMARU Akihisa
Second Department of Internal Medicine, Hyogo College of Medicine
-
Saijo Nagahiro
Department Of Internal Medicine National Cancer Center Hospital
-
HORIUCHI Atsushi
Third Department of Internal Medicine, Kinki University School of Medicine
-
Kanamaru Akihisa
Second Department Of Internal Medicine Hyogo College Of Medicine
-
Naoe Tomoki
Department Of Hematologly And Oncology Nagoya University School Of Medicine
-
FURUSE Kiyoyuki
Department of Internal Medicine, National Kinki Central Hospital
-
FUKUOKA Masahiro
Fourth Department oflnternal Medicine, Kinki University School of Medicine
-
KUNIKANE Hiroshi
Department of Respiratory Medicene, Yokohama Municipal Citizen's Hospital
-
WATANABE Koshiro
Department of Respiratory Medicene, Yokohama Municipal Citizen's Hospital
-
MASAOKA Tohru
Fifth Department of Internal Medicine, Osaka Medical Center for Cancer and Cardiovascular Diseases
-
Kagami Yoshitoyo
Department Of Hematology And Chemotherapy Aichi Cancer Center
-
Kishimoto Susumu
Osaka Univeristy Medical School.the 3rd Dept.of Internal Medicine
-
Kishimoto Susumu
Osaka Prefectural Habikino Hospital
-
FUKUOKA Masahiro
TZT-1027 Cooperative Study Group
-
Naoe Tomoki
Department Of Internal Medicine Tochigi Cancer Center
-
Masaoka Tohru
Fifth Department Of Internal Medicine Center For Abult Disease
-
Masaoka Tohru
Fifth Department Of Internal Medicine Osaka Adult Disease Center
-
KANO Yasuhiko
Department of Internal Medicine, Tochigi Cancer Center
-
OGURO Masao
Department of Hematology and Chemotherapy, Chiba Cancer Center
-
OHNO Ryouzo
Third Department of Internal Medicine, Hamamatsu University School of Medicine
-
SAMPI Kazumi
Department of Hematology Clinic, Saitama Cancer Center
-
SHIRAKAWA Shigeru
Second Department of Internal Medicine, Mie University School of Medicine
-
FURUE Hisashi
Fourth Department of Internal Medicine, Teikyo University School of Medicine
-
Oguro Masao
Department Of Hematology And Chemotherapy Chiba Cancer Center
-
Ohno Ryouzo
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Sampi Kazumi
Department Of Hematology Clinic Saitama Cancer Center
-
Furue Hisashi
Fourth Department Of Internal Medicine Teikyo University School Of Medicine
-
Horiuchi Atsushi
Third Department Of Internal Medicine Kinki University School Of Medicine
-
Kagami Yoshitoyo
Department Of Hematology And Cell Therapy Aichi Cancer Center
-
Kano Yasuhiko
Department Of Internal Medicine Tochigi Cancer Center
-
Furuse Kiyoyuki
Department Of Internal Medicine National Kinki Central Hospital For Chest Diseases
-
Fukuoka Masahiro
Fourth Department Of Internal Medicine Kinki University School Of Medicine
-
Shirakawa Shigeru
Second Department Of Internal Medicine Mie University School Of Medicine
-
Ariyoshi Y
Aichi Prefectural Hospital Okazaki Jpn
-
Ariyoshi Yutaka
Department Of Internal Medicine Aichi Prefectural Hospital
-
IKEGAMI Harumichi
Department of Internal Medicine, Osaka Medical Center for Cancer and Cardiovascullar Diseases
-
Horiuchi Atsushi
Third Department Of Internai Medicine Kinki University Sohool Of Medicine
-
Kunikane Hiroshi
Department Of Respiratory Medicene Yokohama Municipal Citizen's Hospital
-
Kunikane Hiroshi
Department Of Respiratory Medicine Yokohama Municipal Citizen's Hospital
-
Ikegami Harumichi
Department Of Internal Medicine Osaka Medical Center For Cancer And Cardiovascullar Diseases
-
Saijo Nagahiro
Department Of Medical Oncology And Radiation Oncology National Cancer Center Central Hospital
-
Watanabe Koshiro
Department Of Respiratory Medicine Yokohama Municipal Citizen's Hospital
-
Watanabe Koshiro
Department Of Pulmonary Medicine Yokohama Municipal Citizen's Hospital
著作論文
- Feasibility of salvage chemotherapy for refractory or relapsed non-Hodgkin's lymphoma with two topoisomerase II inhibitors, MST-16 and VP-16
- Double-blind randomized control trial of the effect of recombinant human erythropoietin on chemotherapy-induced anemia in patients with non-small cell lung cancer